SAN FRANCISCO (MarketWatch) -- Possis Medical Inc. said Monday it has received marketing approval from the Food and Drug Administration for its AngioJet Ultra Thrombectomy System, the next-generation ...
Boston Scientific Corporation BSX is in the process of conducting a Medical Device Correction of certain AngioJet Ultra Consoles, which were shipped to customers without the required operator’s manual ...
Boston Scientific ($BSX) announced simultaneous approval to market its AngioJet ZelanteDVT thrombectomy catheter for treating deep vein thrombosis in the U.S., Europe ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. © 2025 American City Business Journals. All rights ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results